Works matching IS 13524585 AND DT 2025 AND VI 31 AND IP 2


Results: 12
    1
    2
    3
    4

    DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.

    Published in:
    Multiple Sclerosis Journal, 2025, v. 31, n. 2, p. 159, doi. 10.1177/13524585241303489
    By:
    • Corboy, John R;
    • Fox, Robert J;
    • Cutter, Gary;
    • Engebretson, Eric;
    • Miller, Aaron;
    • Morgan, Charity;
    • Gustafson, Tarah;
    • Goodman, Andrew D;
    • Kannan, Meena;
    • Sriram, Subramanian;
    • Xia, Zongqi;
    • Lynch, Sharon;
    • Bowen, James;
    • Kister, Ilya
    Publication type:
    Article
    5
    6
    7

    From "invisible" to "audible": Features extracted during simple speech tasks classify patient-reported fatigue in multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal, 2025, v. 31, n. 2, p. 231, doi. 10.1177/13524585241303855
    By:
    • Nylander, Alyssa;
    • Sisodia, Nikki;
    • Henderson, Kyra;
    • Wijangco, Jaeleene;
    • Koshal, Kanishka;
    • Poole, Shane;
    • Dias, Marcelo;
    • Linz, Nicklas;
    • Tröger, Johannes;
    • König, Alexandra;
    • Hayward-Koennecke, Helen;
    • Pedotti, Rosetta;
    • Brown, Ethan;
    • Halabi, Cathra;
    • Staffaroni, Adam;
    • Bove, Riley
    Publication type:
    Article
    8
    9
    10
    11
    12